Share on LinkedInShare on LinkedIn

ARTICLE · 05 AUGUST 2019

The State AG Report Weekly Update August 1, 2019

Cozen O'Connor
Explore more from Cozen O'Connor

California AG Xavier Becerra reached a settlement with pharmaceutical company Teva Pharmaceutical Industries Ltd. and its wholly-owned subsidiaries over allegations that its agreements with other pharmaceutical companies ...

United StatesAntitrust/Competition Law
Lori Kalani
Lori Kalani
Bernard Nash
Bernard Nash

ANTITRUST

California Attorney General Announces Settlement with Pharmaceutical Company Over Allegedly Anticompetitive Patent Settlement

  • California AG Xavier Becerra reached a settlement with pharmaceutical company Teva Pharmaceutical Industries Ltd. and its wholly-owned subsidiaries (collectively, "Teva") over allegations that its agreements with other pharmaceutical companies violated state antitrust and consumer protection laws and the federal Sherman Act and Clayton Act.
  • According to the settlement, Teva allegedly entered into "pay-for-delay" agreements—in which a brand company pays a generic company to keep a competing drug off the market—with other pharmaceutical companies, thereby impeding consumer access to lower-priced generic alternatives to Teva's branded drug Provigil.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

Register for freeORLog in

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

View source

Related Articles

Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics

Read more about

Related Comparative Guides

See more popular content from

Article

Booking Holdings v. Commission: General Court Clears The Way For Reverse Leveraging

The General Court of the European Union has upheld the European Commission's prohibition of Booking Holdings' acquisition of eTraveli Group, endorsing for the first time a 'reverse leveraging' theory of harm in conglomerate mergers. This landmark judgment establishes that dominant companies can be blocked from acquiring complementary businesses even when the target operates in a market where the acquirer lacks dominance, fundamentally reshaping merger control enforcement in digital and ecosystem-driven mark
United StatesAntitrust/Competition Law
Baker Botts L.L.P.
Baker Botts L.L.P.
Article

KKR Agrees To Historic $250 Million Penalty For Alleged Violations Of HSR...

The Department of Justice announced a landmark $250 million settlement with KKR & Co. for allegedly submitting deficient Hart-Scott-Rodino Act notification forms across at least 16 transactions. This unprecedented penalty, the largest ever for HSR violations, raises critical questions about merger notification compliance obligations and the consequences of systemic noncompliance with federal antitrust review requirements.
United StatesAntitrust/Competition Law
Bracewell LLP
Bracewell LLP
Article

Recent Significant Federal Merger Enforcement Developments

The Justice Department has resumed targeted Second Request investigations to expedite merger reviews, while major entertainment industry consolidation faces legal challenges and the FTC secures record penalties for Hart-Scott-Rodino Act violations. These developments signal a shifting landscape in federal merger enforcement, balancing efficiency with rigorous antitrust scrutiny across multiple industries.
United StatesAntitrust/Competition Law
Wiggin and Dana LLP
Wiggin and Dana LLP
Article

DOJ Merger Investigation Closure Credits AI Competition And Highlights Targeted Second Request Reviews

The U.S. Department of Justice recently closed its investigation into a merger between two leading sales enablement software providers, citing AI competition as a key protective factor against potential competitive harm. This decision offers important insights into how antitrust agencies are evaluating AI-native companies as competitive constraints and implementing more efficient, targeted merger review processes in technology sector transactions.
United StatesAntitrust/Competition Law
A&O Shearman
A&O Shearman